← FDA DRUG APPROVALS

FDA NDA · NDA018509

BAROS

Sponsor: MALLINCKRODT INC

APPLICATION
NDA018509
TYPE
NDA
ORIGINAL APPROVAL
1985-08-07
LATEST ACTION
1994-01-06
ROUTE
ORAL
DOSAGE FORM
GRANULE, EFFERVESCENT
MARKETING STATUS
Discontinued

Products

BAROSDiscontinued
SODIUM BICARBONATE 460MG/GM, TARTARIC ACID 420MG/GM · GRANULE, EFFERVESCENT · ORAL

Approval history

1994-01-06Manufacturing (CMC) · Supplement 4 · standardAP
1992-09-21Labeling · Supplement 3AP
1987-05-04Manufacturing (CMC) · Supplement 1 · standardAP
1985-08-07Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →